Mission First-in-Class Pipeline

Scioto is developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.

Our unique Activated Bacterial Therapeutic (ABT) platform leverages live therapeutic bacteria biofilms pre-colonized on microspheres allowing for enhanced function and persistent benefit.

Research and Development
First-in-Class Pipeline
Play Video